MPI Research is accredited by the Association for Assessment and

MPI Research is accredited by the Association for Assessment and Accreditation of Laboratory selleck chemicals llc Animal Care International (AAALAC International), and was under guidance of IACUC. Vaccinations with the nanoparticle vaccine and saline control were administered by injection between the skin and underlying layers of tissue in the thigh region of each animal. The same injection site on each animal was used for each administration unless a reaction at the injection site indicated that another site must be used. All injection sites were marked and identified throughout the course of

the study. The dose was administered by bolus injection. Monkeys were immunized (N = 10 per group) on days −78 and −48 with a combined pediatric diphtheria/tetanus

toxoid vaccine, and then immunized on days 1, 29, and 57 with saline, or escalating doses of 1 mL of nanoparticle vaccine at 0.5, 2.0, 8.0 and 16.0 mg/mL. Blood was collected on days shown, prior to immunization (day 1) and then on days 29, 57, 85, 113, and 141 to test for anti-nicotine antibodies. Peripheral blood was collected on day 85 for T cell recall analysis (3 mL) and PBMC isolated by percoll centrifugation. Briefly, human peripheral blood mononuclear cells (PBMCs) were isolated from normal human donors (Research Blood Components, Cambridge, MA). Blood was Pfizer Licensed Compound Library nmr diluted 1:1 in phosphate buffered saline and then 35 mL overlaid on top of 12 mLs Ficoll-Paque premium

(GE Healthcare, Pittsburgh, PA) in a 50 mL centrifuge tube. Tubes were spun at 1400 RPM for 30 min, and the transition phase PBMCs collected, diluted in PBS with 2% fetal calf serum and spun at 1200 rpm for 10 min. Cells were re-suspended in cell freezing media (Sigma–Aldrich, St. Louis, MO) and immediately frozen at −80 °C. For long term storage, cells were transferred to liquid nitrogen. For rhesus monkey PBMC isolation the protocol was the same except 5 mL of blood was collected and processed. to For cynomolgus monkey PBMC, 3 mL of blood was processed, buffy coat was collected and overlaid on 60% Percoll (GE Healthcare), centrifuged 30 min at 1755 rpm, washed and frozen as described above. Frozen PBMC were thawed (37 °C water bath), re-suspended in PBS 10% FCS, spun down and re-suspended to 5 × 106 cells/mL in tissue culture media (RPMI), supplemented with 5% heat inactivated human serum (Sigma–Aldrich), l-glutamine, penicillin and streptomycin, (Gibco, Grand Island, NY). For memory T cell recall response assays, cells (0.6–1.0 mL) were cultured in 24-well plates with 4 μM peptide (GenScript) at 37 °C 5% CO2 for 2 h. One μL of 1000× Brefeldin A (BD, San Jose, CA) per mL of culture media was then added and cells returned to a 37 °C incubator for 4–6 h. Cells were then incubated at 27 °C, 5% CO2 for 16 h.

On the other hand, barriers more commonly discussed in the litera

On the other hand, barriers more commonly discussed in the literature were: the lack of data on hepatitis A disease, cost-effectiveness and other economic data, combination vaccines for hepatitis A, and the potential for safety and effectiveness data of the vaccine to facilitate decision making. Immunization budget or price of the vaccine, and outbreaks of hepatitis A were the only factors consistently discussed by both sources. Our analysis identified gaps between the published literature and what key stakeholders believe about epidemiologic data, economic data and barriers Gefitinib mw and facilitators of vaccine adoption for hepatitis A in six countries. The results of this

study highlight several areas in which having data from both the literature review and stakeholder interviews provided additional insights into the factors driving policy decisions for the hepatitis A vaccine.

Regarding the evidence in support of an epidemiologic transition for hepatitis A seroprevalence, we found that most often the stakeholders were aware of the existing data or that very little data existed. However, in Chile and Russia, stakeholders believed the data to be more supportive of their positions or more solid than the literature could document. This discrepancy between the belief in existing data and what was found suggest a decline in investment in data collection or priority of hepatitis A, perhaps due to a reliance on improvements in hygiene and sanitation. The lack of solid data on current seroprevalence rates underscores the potential for outbreaks and a lingering buy Luminespib threat of hepatitis A. In India and Mexico, although there was recognition that data were lacking, there were a surprisingly small number of seroprevalence studies

despite the size of these countries. Our findings of limited economic data were consistent between the literature and the interviews. However, investigation into the four economic models identified areas in which current economic modeling falls short in meeting the needs of policy makers and in utilizing the best and most relevant data for supporting country specific decision below making. Our review suggests the need for additional investment in economic analyses using country specific data. Finally, comparison of the barriers and drivers of hepatitis A vaccine adoption noted several differences in factors emphasized by the literature and stakeholders. For example, political will and prioritization of vaccines were barriers rarely mentioned in the literature. These data clearly demonstrate that neither source alone would have provided the complete picture of relevant factors. Despite the benefits of using two separate methods for assessing hepatitis A vaccine policy decision making, our results are limited by the search strategies for the literature review and the sampling frame for interviews.

14 and 15 The in vitro method measures the reduction

of t

14 and 15 The in vitro method measures the reduction

of the irradiation by measuring transmittance after passing through a film of product. As in the operative conditions of the transmission measurement are correct, this to be a very precise and single value, always reproducible for the same product and expressed as a single UV curve, in the percent transmittance or absorbance scale (Fig. 1). The crude R. kordesii petal extract, the gel formulation (1.5% carbomer 937) containing R. kordesii petal extract were analyzed for the in vitro SPF. The selleck chemicals llc crude R. kordesii petal extract gel formulation was dissolved in methanol UV solv:water (6:4). Scans of the samples in solution were run from 320 to 290 nm using 1 cm quartz cuvettes in a Shimadzu UV-1700 spectrophotometer. 16 The commercial sunscreens, Himalaya® SPF 30, were used for the calculation of the correction factor and a solution of 8% homosalate (v/v) diluted to 0.2 μg/ml was used as standard. The SPF model used in this study was based on the following equation proposed by Mansur et al. 17 equation(1) SPF=CF×∑290320EE(λ)×I(λ)×abs(λ)where CF is correction factor, determined by sunscreens with known SPF, so that a solution containing 8% of

homosalate gives SPF = 8; EE(λ) the erythemal efficiency spectrum; I(λ) the solar simulator spectrum as measured with a calibrated spectroradiometer; equation(2) ∑290320EE(λ)×I(λ)=290–320nmwhere, KRX-0401 manufacturer GPX6 290–320 nm in 5 nm

increments; abs(λ) is the spectroradiometer measure of sunscreen product absorbance. Table 3 shows the normalized values of the product function used in these studies and were calculated by Sayre et al. 17 and 18 The data were analyzed statistically by factorial analysis of variance (ANOVA). The Tukey–Kramer test was then used to determine significant differences between groups. The chemical stability of the R. kordesii root extract gel was determined according to the concentration of R. kordesii extracts at different storage temperatures (5, 25 and 45 °C) for 3–4 months. The final concentration was expressed as micrograms of R. kordesii extracts per gram of gel formulation. Carbomer frequently interacts with cationic drugs and excipients due to its numerous carboxylic acid groups. 19 In vitro studies using carbomers 973 showed that its interaction with substances commonly used in the pharmaceutical industry, such as lidocaine and mebeverine hydrochloride, was a function of pH, drug, polymer concentration and electrolytes. 20 All samples stored at 5 and 25 °C were stable over the time of experiment (3–4 months). All of them showed an initial decrease (20%) between days 0 and 1 and then remain constant over time. The samples stored at 45 °C were stable up 7 days then the degradation of gel structure was observed after 7 days. The correction factor was calculated for commercial sunscreen (Himalaya® SPF 30) using Eq.

, 1997 and Roozendaal et al , 2009) Stressors activate the HPA-a

, 1997 and Roozendaal et al., 2009). Stressors activate the HPA-axis through the release of corticotropin-releasing hormone (CRH) from the paraventricular nucleus (PVN) of the hypothalamus. When CRH reaches the anterior pituitary gland, it elicits adrenocorticotropic hormone (ACTH) release, which prompts glucocorticoid synthesis in the adrenal glands. Finally, glucocorticoids are released into the bloodstream where they travel and bind to receptors throughout the body and brain (McEwen et al., 1986,

de Kloet, 2004 and Sapolsky et al., 2000). Glucocorticoid release follows a slower time course than rapidly released catecholamines, peaking Selleck JNK inhibitor 10–20 min after the onset of stress exposure (Sapolsky et al., 2000). Glucocorticoids are often characterized as a recovery hormone that adapts an organism to the neurophysiological changes that occur during stress (Lupien et al., 2007). Collectively, these two systems interact and function in a complementary manner to mobilize energy and help an organism cope with stressful experiences. Despite the inability of peripheral catecholamines to cross the blood–brain barrier, noradrenaline is projected throughout

the brain by way of the locus coeruleus (LC). The LC serves as the brain’s primary source of noradrenaline and shares reciprocal connections with brain regions that are critical to the acquisition and regulation of conditioned fear, such Kinase Inhibitor Library price as the amygdala, hippocampus and PFC (Benarroch, 2009). The high proportion of noradrenaline receptors in the amygdala and PFC render these brain regions SB-3CT especially sensitive to the effects of stress (McEwen et al., 1986). Circulating glucocorticoids can influence brain function by readily crossing the blood–brain barrier and binding to high-affinity mineralocorticoid and low-affinity glucocorticoid receptors distributed throughout the amygdala, hippocampus and prefrontal cortex (Joels et al., 2012 and Lupien et al., 2007). The effects

of glucocorticoids include dampening glucose transport within cortical neurons and glia cells, which may further influence brain function by diminishing processing and amplifying the effects of early catecholamine release by slowing their clearance from synaptic space (Grundemann et al., 1998, Ferry et al., 1999 and Roozendaal et al., 2002). The release of glucocorticoids is controlled through negative feedback mechanisms housed within the PFC, suggesting that this region is targeted both for glucocorticoid binding under stress and for the regulation of glucocorticoid release (Diorio et al., 1993). Consistent with this, both chronic exposure to stress and affective psychopathology have been shown to be related to deficits in HPA regulation and inhibition (Cacioppo et al., 1998, Nyklicek et al., 2005 and Radley et al., 2006). Learning to respond appropriately to cues that signal danger is critical to survival and can facilitate adaptive behavior.

The percentage of inhibition of ferrozine-Fe2+ complex formation

The percentage of inhibition of ferrozine-Fe2+ complex formation was given in the underneath formula. Ferrousionschelatingability(%)=[(A0−A)/A0]×100Where,

A0 is the absorbance of the control solution (containing all reagents except plant extract); A is the absorbance in the presence of the sample of plant extracts. Three replicates were made for each test sample and average data was noted. Here, EDTA was used as positive control standard. The total phenolic contents of the extracts were determined by the modified Folin–Ciocaltu method.14 Briefly, 0.5 ml of each extract (1 mg/ml) was mixed with 5 ml Folin–Ciocaltu reagent (1:10 v/v distilled GSK J4 in vitro water) and 4 ml (75 g/L) of Sodium carbonate. The mixture was vortexed for 15 s and allowed to stand for 30 min at 40 °C for color development. The absorbance was read at 765 nm with a spectrophotometer see more (UV-1800, Shimadzu, Japan). Total phenolic content was determined as mg of gallic acid equivalent per gram using the equation obtained from a standard gallic acid calibration curve. For antioxidant determination, data were presented as mean ± Standard deviation (SD). Statistical analysis for animal experiment was carried out using one-way ANOVA followed by Dunnett’s multiple comparisons using SPSS 16.0 for Windows®. The results obtained were

compared with the control group. p values < 0.05 were considered to be statistically significant. A dose-dependent analgesic potential was showed by the crude extract of A. conyzoides and M. cordifolia leaves ( Table 1). The analgesic activities of both plants were significant (p < 0.05) at the dose of 500 mg/kg-body weight in comparison with control

animals; however, the activity was less than that of diclofenac Na (standard). In the study, A. conyzoides extract was found more effective Metalloexopeptidase than that of M. cordifolia L. The investigation shows that DPPH free radical scavenging activity of crude ethanolic extracts of A. conyzoides and M. cordifolia leaves were found to be increased with the increase of concentrations of the extracts ( Fig. 1). The extracts exhibited 91.72 ± 0.053% and 85.12 ± 0.087% inhibition respectively at the concentration of 100 μg/ml, whereas standard Ascorbic acid (AA) and BHA showed 95.86 ± 0.031% and 93.099 ± 0.019% inhibition respectively at the same concentration. In the study, if the IC50 value is less than 30 μg/ml, be considered as strong scavenging activity; 30 ≤ IC50 ≤ 100 μg/ml as moderate, and IC50 > 100 μg/ml be considered as weaker activity. 15 Therefore, it can be revealed that A. conyzoides got strong free radical scavenging activity (IC50 (μg/ml) = 18.91 ± 0.085), whereas M. cordifolia got moderate scavenging activity (IC50 (μg/ml) = 39.81 ± 0.081).

Le groupe de travail chargé de l’actualisation des « Standards Op

Le groupe de travail chargé de l’actualisation des « Standards Options Recommandations » de 2002 [8], [9] and [10], a récemment publié une mise à jour concernant le fentanyl transmuqueux d’action rapide [11] and [12]. La prochaine actualisation portera sur « la rotation d’opioïdes » ou « changement d’opioïdes ». Face à une douleur cancéreuse, il est toujours recommandé d’associer des médicaments de mode d’action différent, notamment : • des antalgiques de paliers différents ; On dispose aujourd’hui d’un arsenal thérapeutique étendu de traitements antalgiques, et notamment d’opioïdes forts dont l’efficacité antalgique et le profil PD173074 in vitro de tolérance sont check details globalement les mêmes

[14] and [15], hormis une moindre incidence de constipation avec le fentanyl transdermique [16](encadré 2). Palier I : antalgiques non opioïdes • Paracétamol – AINS – Acide acétylsalicylique Palier II : opioïdes faibles • Codéine associée au paracétamol : Efferalgan-Codéine®, Co-Doliprane®, Dafalgan-codéine®, Klipal Palier III : opioïdes forts Opioïdes forts agonistes purs (voir tableaux) • Morphine Face à une douleur nociceptive, si un antalgique de palier II à posologie optimale devient inefficace, on prescrira une molécule de palier III (morphine ou oxycodone)

et l’initiation comportera une phase de titration. Cependant, face à une douleur intense, un antalgique de palier III peut être prescrit d’emblée, sans passer par le palier II. Selon les recommandations de l’Association européenne de soins palliatifs (EAPC) de 2012 [17], on peut soulager une douleur cancéreuse légère à modérée, avec des opioïdes forts d’emblée, sans effets indésirables majeurs. Il est donc possible de les prescrire en première intention pour traiter une douleur cancéreuse nociceptive, Non-specific serine/threonine protein kinase quelle que soit l’intensité douloureuse, en adaptant la posologie [18] and [19]. La période de titration

initiale consiste à déterminer les besoins du patient en opioïdes forts, c’est-à-dire à définir la posologie minimale qui permettra d’obtenir un soulagement satisfaisant du patient. Deux méthodes existent : soit l’administration à intervalles réguliers d’une dose fixe d’opioïde fort à libération prolongée (LP), s’il existe une douleur de fond, associée à des doses de secours ou interdoses d’opioïdes à libération immédiate (LI) en fonction des accès douloureux ; soit l’administration à la demande, en fonction de l’intensité des douleurs, d’opioïdes à LI seuls, au maximum six fois par jour (encadré 3). La titration permet une adaptation fine du traitement antalgique, qui conduit à une meilleure gestion de la douleur par le patient (autocontrôle), avec le minimum d’effets indésirables, du fait de l’utilisation de la dose juste nécessaire.

A study by Pelat et al (2009) illustrated that searches for gast

A study by Pelat et al. (2009) illustrated that searches for gastroenteritis were significantly

correlated with incidence of acute diarrhea from the French Sentinel Network. Other studies leveraging data from social media (such as Twitter) have been able to track reports of foodborne illnesses and identify clusters suggesting outbreaks (Ordun et al., 2013 and Sadilek et al., 2013). Most individuals who experience foodborne illnesses do not seek medical care but might be willing to share their experiences using social media platforms. By harnessing the data available through these novel sources, automated data mining processes can be developed for identifying and monitoring reports of foodborne illness and disease outbreaks. Continuous monitoring, rapid detection, and investigation of foodborne disease outbreaks are crucial for limiting the spread of contaminated food products selleck kinase inhibitor and for

preventing reoccurrence by prompting changes in food production and delivery systems. The authors of this paper report no financial disclosures. The funding source had no role in the design and analysis of the study, and selleck writing of the manuscript. The authors declare no conflict of interest. This work is supported by a research grant from the National Library of Medicine, the National Institutes of Health (5R01LM010812-03). “
“Men are known to have a shorter life expectancy and higher mortality compared to women (Lynch, 2013, Wang et al., 2013, White and Holmes, 2006 and White et al., 2014). This could be attributed to men indulging in higher risk-taking behaviors, reluctance to seek help for prevention and during illness and the lack of male-focused oxyclozanide health system (Addis and Mahalik,

2003, Byrnes et al., 1999, Cordier and Wilson, 2013, Lynch, 2013, Tan et al., 2007 and White and Holmes, 2006). In addition, men’s health reports from Australia, Canada and Europe found significant variations in men’s health status within and across different countries (AIHW, 2013, Bilsker et al., 2010 and EC, 2011), which could be due to the differences in genetic as well as socio-economic factors. (Ncin and Cancer Research Uk, 2009 and White et al., 2011). Asia is rapidly developing both economically and socially. In recent years, more Asian countries are achieving a higher bracket in terms of socioeconomic status, and many are adopting a lifestyle similar to western countries (Tong et al., 2011 and Wassener, 2013). However, communicable and non-communicable diseases are on the rise in Asia (Wassener, 2013). While people from higher-income countries are achieving better health status, countries from the middle- and lower-income group continue to face higher disease burden, possibly attributed to financial constraints (Orach, 2009 and WHO, 2000).

Dans les addictions avec substance, le topiramate a montré un int

Dans les addictions avec substance, le topiramate a montré un intérêt principalement dans l’alcoolodépendance. Néanmoins, la fréquence des effets indésirables fait que ce médicament ne peut être utilisé en

première intention, mais après les traitements habituels. Il n’existe que peu d’études dans les autres addictions. La prudence est de mise pour les addictions pour lesquelles il n’existe pas de traitements validés, telles que la dépendance à la cocaïne et la dépendance à la méthamphétamine. Dans les addictions comportementales, le topiramate a montré un intérêt, principalement dans la boulimie et le binge eating disorder. Dans la boulimie, l’American Psychiatric Association (APA) a recommandé que le topiramate ne soit utilisé qu’en cas d’inefficacité des autres traitements en raison de ses effets indésirables fréquents. La tendance du topiramate à induire une PARP activity perte de poids a été relevée comme problématique chez les patients avec un poids normal ou inférieur à la normale (IMC < 20 kg/m2) [69]. Dans le futur, la réalisation d’essais cliniques sur l’utilisation du topiramate en addictologie chez des patients ayant une comorbidité psychiatrique permettrait de mieux refléter la réalité des pratiques

au quotidien, ce dans la mesure où la corrélation entre troubles psychiatriques et troubles liés à une substance est bien établie. les auteurs déclarent ne pas avoir de conflits Enzalutamide ic50 d’intérêts en relation avec cet article. “
“Le diagnostic et la classification des hypertensions pulmonaires (HTP) ont été au centre des débats de plusieurs symposiums au cours de ces quarante dernières années : Genève 1973, Evian 1998, Venise 2003, Dana Point 2008 et Nice en 2013. La dernière définition de l’HTP tient compte de la pression artérielle pulmonaire moyenne (PAPm) mesurée au moment du cathétérisme cardiaque droit, qui doit être supérieure ou égale à 25 mmHg [1]. Pour le moment, nous ne disposons pas de suffisamment de données pour pouvoir définir une hypertension pulmonaire à l’effort [1]. L’ancienne

ALOX15 définition qui parlait d’une PAPm à l’effort ≥ 30 mmHg a été abandonnée en 2008, principalement en raison d’une grande variabilité de l’hémodynamique à l’effort selon l’âge et de l’impossibilité d’imposer un standard unique pour l’épreuve d’effort. L’hypertension artérielle pulmonaire (HTAP) est définie par une PAPm ≥ 25 mmHg, une pression capillaire pulmonaire (PCP) ≤ 15 mmHg (télé-expiratoire) et des résistances vasculaires pulmonaires (RVP) > 3 unités Wood au moment du cathétérisme cardiaque droit [1]. Les RVP sont calculées en tenant compte du débit cardiaque (DC) selon la formule : (PAPm-PCP) / DC. L’examen essentiel pour le diagnostic de l’hypertension pulmonaire est le cathétérisme cardiaque droit.

Proteins destined for the ER are identified by a short leading se

Proteins destined for the ER are identified by a short leading sequence of hydrophobic amino acids at the N-terminus end, which is recognised by the signal recognition particle, a ribonucleoprotein within the cytosol. Synthesis of all proteins starts on a ribosome free within the cytosol, but when the ER signal sequence is recognised by the signal recognition particle the latter binds the ribosome complex to a receptor on the outer surface of the ER membrane. This arrangement creates the characteristic beaded appearance at the ultrastructural

level referred to as rough endoplasmic reticulum, and enables the nascent polypeptide chain to be threaded through a translocation channel, the PCI-32765 molecular weight translocon, into the ER lumen. Once within the lumen, the signal sequence is cleaved, and chaperone proteins bind to the polypeptide chain to prevent premature and inappropriate folding. Glucose-regulated protein GRP78/BiP, a member of the HSP70 family, binds to hydrophobic amino acid groups of secretory proteins, and facilitates folding through the hydrolysis of ATP by an ATPase domain. Calnexin and calreticulin are specifically involved in the folding of glycoproteins, binding to monoglucosylated N-linked glycans [13]. The ER also acts as a major intracellular see more store of calcium, and the concentration within the lumen is often several thousand-fold higher than in the cytosol, reaching millimolar

levels [14]. This gradient is maintained by the activity of Ca2+-ATPases within the ER membrane, and is considered necessary for functioning of the protein folding machinery and chaperone proteins [15]. Correct folding into the secondary and tertiary conformation, and assembly into multimeric complexes, is essential for the functional competence of many proteins. For the extracellular proteins passing through the ER this most commonly involves the formation of covalent disulfide bonds between cysteine side chains, either within different parts Adenylyl cyclase of a polypeptide chain

or between two such chains. For example, the alpha sub-unit of human chorionic gonadotropin contains five disulphide bonds, while the beta sub-unit contains six [16]. Formation of disulfide bonds is an oxidative event, and consequently the ER is a site of significant production of reactive oxygen species (ROS) within the cell [17]. During the formation of a disulfide bond electrons are first removed from the cysteine thiol groups by the enzyme protein disulfide isomerase, PDI, and are transferred to molecular oxygen by the enzyme ER oxidoreduction, ERO1, using FAD as an intermediate. Because of the kinetics, full reduction of oxygen may not occur, in which case ROS intermediates such as hydrogen peroxide will be produced [17]. Consequently, the ratio of reduced to oxidised glutathione, the principal redox buffer within the ER lumen, is approximately 3:1 compared to that of approximately 100:1 in the cytosol [18].

All pandemic vaccines used in LAC were well tolerated and elicite

All pandemic vaccines used in LAC were well tolerated and elicited mainly mild or moderate adverse reactions; surveillance efforts did not find signs of an increased risk of severe ESAVI, when compared with seasonal influenza vaccination. These data have several selleckchem limitations, principally that most ESAVI surveillance systems in LAC are passive, which can under-report the real frequency of ESAVI in the vaccinated population. Although efforts were made to support countries in their risk communication activities, work remains to be done to strengthen this important component. Many countries

faced a general mistrust of the pandemic influenza (H1N1)

vaccine due to widespread misinformation regarding vaccine safety and the use of adjuvant, among others. Many rumors began in developed countries and then spread to LAC countries through the media and social networks. For the success of future pandemic response efforts, pandemic preparedness plans need to include open and effective communication strategies to build public confidence and emphasize the importance of influenza vaccination. The first influenza pandemic of the 21st century resulted in many lessons learned. Globally, LAC was among the regions with the greatest implementation of pandemic vaccination, despite facing check details many challenges. Additional steps must now be taken, at the national and international levels to ensure that, for the next pandemic, low and middle-income countries will have equitable and timely access to pandemic vaccines and that effective risk communication strategies will be implemented proactively. First, the authors would like to acknowledge the hard work and extraordinary Rolziracetam dedication of national teams and health workers responsible for the implementation

of pandemic influenza (H1N1) vaccination campaigns across Latin America and the Caribbean. The authors would also like to thank multiple individuals who contributed to planning and implementation of the pandemic influenza vaccination activities at the regional level. From PAHO, Dr. Carlos Castillo and Ms. Pamela Bravo provided technical cooperation to countries in capacity-building for ESAVI surveillance; Ms. Monica Pereira managed the operational activities of the Revolving Fund; Ms. Bryna Brennan coordinated the work of risk communication consultants sent to some support national immunization programs and Dr. Maria de los Angeles Cortes Castillo was involved in the coordination of regulatory issues with national authorities.